InsidersTradesSigma
Follow the 恩威医药 share price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 恩威医药 has published 1 public disclosures. Market capitalisation: €2bn. The latest transaction was reported on 26 August 2025 (Sale). Among the most active insiders: 陈磊. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
恩威医药是一家专注于医疗保健和制药领域的公司，在 XSHE 市场上市。该公司致力于创新医药产品的开发和商业化。